Review



human urinary bladder carcinoma epithelial cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    ATCC human urinary bladder carcinoma epithelial cells
    Human Urinary Bladder Carcinoma Epithelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 2718 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+urinary+bladder+carcinoma+epithelial+cells/us12544420-70-7-27?v=ATCC
    Average 98 stars, based on 2718 article reviews
    human urinary bladder carcinoma epithelial cells - by Bioz Stars, 2026-07
    98/100 stars

    Images



    Similar Products

    98
    ATCC human urinary bladder carcinoma epithelial cells
    Human Urinary Bladder Carcinoma Epithelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+urinary+bladder+carcinoma+epithelial+cells/us12544420-70-7-27?v=ATCC
    Average 98 stars, based on 1 article reviews
    human urinary bladder carcinoma epithelial cells - by Bioz Stars, 2026-07
    98/100 stars
      Buy from Supplier

    97
    ATCC human urinary bladder epithelial carcinoma cells
    a Growth curves of free uropathogenic E. coli bacteria (UPEC) in presence or absence of the indicated DCAP concentrations. b Measurements of the minimum inhibitory concentration (MIC) of growth against UPEC bacteria of DCAP, CQ or the well-characterized beta-lactam antibiotic, ampicillin. c Immunoblot analysis of protein samples from Bladder <t>Epithelial</t> Cells (BECs) treated 24 h with vehicle (DMSO) or 10 µM DCAP, showing DCAP-mediated accumulation of LC3-II and SQSTM1. GAPDH was used as a loading control. d The potential cytotoxicity of 10 µM DCAP against BECs was evaluated by lactate dehydrogenase (LDH) cytotoxic assay. Indicating the tolerability of BECs toward this dose of compound, cells treated for 24 h showed negligible differences in the release of LDH in the medium, compared with vehicle-treated cells. Reported as percentage of LDH cytotoxicity ± s.e.m., n = 6. e BECs were infected with a pathogenic UTI89 E. coli strain. After the removal of extracellular bacteria by gentamycin, an antibiotic that is not permeable through the human cell membrane, BECs were treated with 10 µM DCAP or vehicle for 24 h. The counting of intracellular bacteria from DMSO- and DCAP-treated infected cells is reported as an average of the colony-forming unit (CFU)/ml ± s.e.m., n = 12. ** P < 0.01 DCAP vs. DMSO (Mann–Whitney test). f Immunoblot analysis of protein extract from BECs transfected with a siRNA sequences against ATG16L1 or a non-targeting element (control). GAPDH was used as a loading control. g Quantification of intracellular UPEC bacteria in infected siATG16L1 and control BECs treated with 10 µM or DMSO. Shown as average CFU/ml ± s.e.m., n = 7. *P < 0.05 DCAP vs. DMSO (Mann–Whitney test)
    Human Urinary Bladder Epithelial Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+urinary+bladder+carcinoma+epithelial+cells/pmc06045594-160-16-27?v=ATCC
    Average 97 stars, based on 1 article reviews
    human urinary bladder epithelial carcinoma cells - by Bioz Stars, 2026-07
    97/100 stars
      Buy from Supplier

    88
    DSMZ human urinary bladder epithelial carcinoma cells
    a Growth curves of free uropathogenic E. coli bacteria (UPEC) in presence or absence of the indicated DCAP concentrations. b Measurements of the minimum inhibitory concentration (MIC) of growth against UPEC bacteria of DCAP, CQ or the well-characterized beta-lactam antibiotic, ampicillin. c Immunoblot analysis of protein samples from Bladder <t>Epithelial</t> Cells (BECs) treated 24 h with vehicle (DMSO) or 10 µM DCAP, showing DCAP-mediated accumulation of LC3-II and SQSTM1. GAPDH was used as a loading control. d The potential cytotoxicity of 10 µM DCAP against BECs was evaluated by lactate dehydrogenase (LDH) cytotoxic assay. Indicating the tolerability of BECs toward this dose of compound, cells treated for 24 h showed negligible differences in the release of LDH in the medium, compared with vehicle-treated cells. Reported as percentage of LDH cytotoxicity ± s.e.m., n = 6. e BECs were infected with a pathogenic UTI89 E. coli strain. After the removal of extracellular bacteria by gentamycin, an antibiotic that is not permeable through the human cell membrane, BECs were treated with 10 µM DCAP or vehicle for 24 h. The counting of intracellular bacteria from DMSO- and DCAP-treated infected cells is reported as an average of the colony-forming unit (CFU)/ml ± s.e.m., n = 12. ** P < 0.01 DCAP vs. DMSO (Mann–Whitney test). f Immunoblot analysis of protein extract from BECs transfected with a siRNA sequences against ATG16L1 or a non-targeting element (control). GAPDH was used as a loading control. g Quantification of intracellular UPEC bacteria in infected siATG16L1 and control BECs treated with 10 µM or DMSO. Shown as average CFU/ml ± s.e.m., n = 7. *P < 0.05 DCAP vs. DMSO (Mann–Whitney test)
    Human Urinary Bladder Epithelial Carcinoma Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+urinary+bladder+carcinoma+epithelial+cells/pm24084294-44-0-17?v=DSMZ
    Average 88 stars, based on 1 article reviews
    human urinary bladder epithelial carcinoma cells - by Bioz Stars, 2026-07
    88/100 stars
      Buy from Supplier

    Image Search Results


    a Growth curves of free uropathogenic E. coli bacteria (UPEC) in presence or absence of the indicated DCAP concentrations. b Measurements of the minimum inhibitory concentration (MIC) of growth against UPEC bacteria of DCAP, CQ or the well-characterized beta-lactam antibiotic, ampicillin. c Immunoblot analysis of protein samples from Bladder Epithelial Cells (BECs) treated 24 h with vehicle (DMSO) or 10 µM DCAP, showing DCAP-mediated accumulation of LC3-II and SQSTM1. GAPDH was used as a loading control. d The potential cytotoxicity of 10 µM DCAP against BECs was evaluated by lactate dehydrogenase (LDH) cytotoxic assay. Indicating the tolerability of BECs toward this dose of compound, cells treated for 24 h showed negligible differences in the release of LDH in the medium, compared with vehicle-treated cells. Reported as percentage of LDH cytotoxicity ± s.e.m., n = 6. e BECs were infected with a pathogenic UTI89 E. coli strain. After the removal of extracellular bacteria by gentamycin, an antibiotic that is not permeable through the human cell membrane, BECs were treated with 10 µM DCAP or vehicle for 24 h. The counting of intracellular bacteria from DMSO- and DCAP-treated infected cells is reported as an average of the colony-forming unit (CFU)/ml ± s.e.m., n = 12. ** P < 0.01 DCAP vs. DMSO (Mann–Whitney test). f Immunoblot analysis of protein extract from BECs transfected with a siRNA sequences against ATG16L1 or a non-targeting element (control). GAPDH was used as a loading control. g Quantification of intracellular UPEC bacteria in infected siATG16L1 and control BECs treated with 10 µM or DMSO. Shown as average CFU/ml ± s.e.m., n = 7. *P < 0.05 DCAP vs. DMSO (Mann–Whitney test)

    Journal: Cell Death & Disease

    Article Title: A broad-spectrum antibiotic, DCAP, reduces uropathogenic Escherichia coli infection and enhances vorinostat anticancer activity by modulating autophagy

    doi: 10.1038/s41419-018-0786-4

    Figure Lengend Snippet: a Growth curves of free uropathogenic E. coli bacteria (UPEC) in presence or absence of the indicated DCAP concentrations. b Measurements of the minimum inhibitory concentration (MIC) of growth against UPEC bacteria of DCAP, CQ or the well-characterized beta-lactam antibiotic, ampicillin. c Immunoblot analysis of protein samples from Bladder Epithelial Cells (BECs) treated 24 h with vehicle (DMSO) or 10 µM DCAP, showing DCAP-mediated accumulation of LC3-II and SQSTM1. GAPDH was used as a loading control. d The potential cytotoxicity of 10 µM DCAP against BECs was evaluated by lactate dehydrogenase (LDH) cytotoxic assay. Indicating the tolerability of BECs toward this dose of compound, cells treated for 24 h showed negligible differences in the release of LDH in the medium, compared with vehicle-treated cells. Reported as percentage of LDH cytotoxicity ± s.e.m., n = 6. e BECs were infected with a pathogenic UTI89 E. coli strain. After the removal of extracellular bacteria by gentamycin, an antibiotic that is not permeable through the human cell membrane, BECs were treated with 10 µM DCAP or vehicle for 24 h. The counting of intracellular bacteria from DMSO- and DCAP-treated infected cells is reported as an average of the colony-forming unit (CFU)/ml ± s.e.m., n = 12. ** P < 0.01 DCAP vs. DMSO (Mann–Whitney test). f Immunoblot analysis of protein extract from BECs transfected with a siRNA sequences against ATG16L1 or a non-targeting element (control). GAPDH was used as a loading control. g Quantification of intracellular UPEC bacteria in infected siATG16L1 and control BECs treated with 10 µM or DMSO. Shown as average CFU/ml ± s.e.m., n = 7. *P < 0.05 DCAP vs. DMSO (Mann–Whitney test)

    Article Snippet: Human osteosarcoma cells U2OS, human embryonic kidney cells 293 (HEK293), human melanoma cancer cells A375 and human urinary bladder epithelial carcinoma cells (5637, HTB9) were acquired from American Type Culture Collection and the National Collection of Type Cultures (ATCC), were grown in Dulbecco’s modified Eagle’s medium (DMEM, Euroclone, ECB7501L) with 4.5 g/L glucose supplemented with 10% fetal bovine serum (FBS, Gibco, 10270106), 2 mM L-glutamine and 1% Penicillin/streptomycin.

    Techniques: Bacteria, Concentration Assay, Western Blot, Control, Infection, Membrane, MANN-WHITNEY, Transfection